← Back to all posts

A new approach to a Covid-19 nasal vaccine shows early promise

Scientists in Germany have developed a nasal vaccine that can shut down Covid-19 infections at their earliest stage, in the nose and throat. The vaccine is made with a weakened form of the coronavirus and has achieved 'sterilizing immunity' in hamsters, blocking virus replication.
Read the original article ↗